BioMr. Albert is responsible for developing the firm’s internal, thesis driven research effort. Having spent almost 15 years as a long/short buy side investor focused on small cap technology, he has developed a very critical approach to evaluating emerging business models. He is currently a board observer at Celigo, Docupace and SmartAction.
Recently, he led the technology investment segment for Merus Capital Partner ....
Education